Product Theater: Managing Continued Treatment for Chronic Moderate to Severe Plaque Psoriasis
Faculty: Paul Yamauchi, MD – Santa Monica, CA
- Assistant Clinical Professor of Dermatology, UCLA’s David Geffen School of Medicine
- Adjunct Associate Professor, John Wayne Cancer Institute, Santa Monica, CA
- Dermatology Residency, UCLA School of Medicine
- Cosmetic Surgery Fellowship, UCLA School of Medicine
This product theater features Dr. Paul Yamauchi speaks in depth about Otezla® (apremilast) for the treatment of psoriasis. He discusses topical steroids versus systemic therapies, and offers tips to help your psoriasis patients make the best treatment decisions.
Posted August 7, 2020